.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Baxter
AstraZeneca
Cerilliant
Cantor Fitzgerald
US Army
Novartis
UBS
Chubb

Generated: December 12, 2017

DrugPatentWatch Database Preview

Technetium tc-99m teboroxime kit - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for technetium tc-99m teboroxime kit and what is the scope of technetium tc-99m teboroxime kit freedom to operate?

Technetium tc-99m teboroxime kit
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Technetium tc-99m teboroxime kit has ten patent family members in seven countries and one supplementary protection certificate in one country.

There are four drug master file entries for technetium tc-99m teboroxime kit.

Summary for technetium tc-99m teboroxime kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
BraccoCARDIOTECtechnetium tc-99m teboroxime kitINJECTABLE;INJECTION019928-001Dec 19, 1990DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: technetium tc-99m teboroxime kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
BraccoCARDIOTECtechnetium tc-99m teboroxime kitINJECTABLE;INJECTION019928-001Dec 19, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: technetium tc-99m teboroxime kit

Country Document Number Estimated Expiration
Japan2003505433► Subscribe
Norway20020239► Subscribe
World Intellectual Property Organization (WIPO)0107089► Subscribe
Norway321254► Subscribe
MexicoPA02000628► Subscribe
Canada2378096► Subscribe
European Patent Office1221978► Subscribe
Australia5838400► Subscribe
Japan4649084► Subscribe
Australia763988► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: TECHNETIUM TC-99M TEBOROXIME KIT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0736Netherlands► SubscribePRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
QuintilesIMS
Medtronic
Federal Trade Commission
Chubb
Baxter
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot